Your browser doesn't support javascript.
loading
Paradoxical cellular effects and biological role of the multifaceted compound nordihydroguaiaretic acid.
Hernández-Damián, Jacqueline; Andérica-Romero, Ana Cristina; Pedraza-Chaverri, José.
Afiliação
  • Hernández-Damián J; Faculty of Chemistry, Department of Biology, National Autonomous University of Mexico (UNAM), University City, D.F., Mexico.
Arch Pharm (Weinheim) ; 347(10): 685-97, 2014 Oct.
Article em En | MEDLINE | ID: mdl-25100573
ABSTRACT
Nordihydroguaiaretic acid (NDGA) is a phenolic compound obtained from the leaves of the evergreen desert shrub Larrea tridentata (Creosote bush), which has been used anciently in folk medicine for the treatment of multiple diseases. At the molecular level, NDGA is a potent scavenger of reactive oxygen species. Lipoxygenase inhibition by NDGA has been broadly studied over several cell models; however, NDGA exerts other antioxidant properties and cytoprotective effects in non-tumor cells, which are related with its role as modulator of the nuclear factor erythroid 2-related factor 2 (Nrf2)/antioxidant response element (ARE) antioxidant pathway. In contrast, in tumor cells NDGA exerts pro-apoptotic activity and anti-tumor effects. Different effects of NDGA have been observed in mitochondria, where NDGA prevents mitochondrial damage in non-tumor cells and induces loss of mitochondrial function in tumor cells. Moreover, NDGA exerts beneficial effects in diverse diseases like cancer, renal damage, Huntington's disease, Alzheimer's disease, and other neurodegenerative pathologies. This work represents a critical review about relevant NDGA mechanisms, cellular effects, and signal pathways involved with possible useful effects.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Masoprocol / Transdução de Sinais / Sequestradores de Radicais Livres / Inibidores de Lipoxigenase / Fármacos Neuroprotetores / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Masoprocol / Transdução de Sinais / Sequestradores de Radicais Livres / Inibidores de Lipoxigenase / Fármacos Neuroprotetores / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article